SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Pastimes : Clown-Free Zone... sorry, no clowns allowed -- Ignore unavailable to you. Want to Upgrade?


To: Lucretius who wrote (178411)7/9/2002 2:25:36 PM
From: MythMan  Read Replies (1) | Respond to of 436258
 
no growth, high valuations (what doesn't fit that description, right?). At some point they gotta be a buy. BMY on yield alone is worth a look see. Plus they could be bought out.

Breakfast at Tiffany's? -g-
>>2:20PM Tiffany & Co sees Q2 at low-end of guidance (TIF) 32.19 -1.39: <<



To: Lucretius who wrote (178411)7/9/2002 3:05:05 PM
From: BigMoney  Respond to of 436258
 
somebody musta started the rumor...
that i was long on pharmas <g>



To: Lucretius who wrote (178411)7/9/2002 3:28:52 PM
From: Oblomov  Respond to of 436258
 
Selloff due to NIH report on HRT effects, maybe?

finance.yahoo.com
biz.yahoo.com

Some pharma companies will benefit greatly from this news.



To: Lucretius who wrote (178411)7/9/2002 8:16:15 PM
From: oldirtybastard  Read Replies (2) | Respond to of 436258
 
pricing in shrub's plan to kill all the old people off, don't you know the pension funds and social security can't support everyone? -g-